Predictions
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€74.66
01.08.23
01.08.23
€87.48
01.08.24
01.08.24
15.51%
28.06.24
28.06.24
Johnson & Johnson
Start price
Target price
Perf. (%)
€151.80
31.07.23
31.07.23
€195.31
31.07.24
31.07.24
-7.21%
28.06.24
28.06.24
Johnson & Johnson
Start price
Target price
Perf. (%)
€151.80
31.07.23
31.07.23
€195.31
31.07.24
31.07.24
-7.21%
28.06.24
28.06.24
Baxter International
Start price
Target price
Perf. (%)
€42.80
31.07.23
31.07.23
€46.23
31.07.24
31.07.24
-24.53%
28.06.24
28.06.24
Medtronic plc
Start price
Target price
Perf. (%)
€80.02
29.07.23
29.07.23
-
29.07.24
29.07.24
-4.71%
28.06.24
28.06.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€511.40
28.07.23
28.07.23
€572.10
28.07.24
28.07.24
1.15%
28.06.24
28.06.24
Boston Scientific
Start price
Target price
Perf. (%)
€47.48
28.07.23
28.07.23
€55.39
28.07.24
28.07.24
51.64%
28.06.24
28.06.24
Align Technology
Start price
Target price
Perf. (%)
€362.60
27.07.23
27.07.23
€377.36
27.07.24
27.07.24
-37.84%
28.06.24
28.06.24
Align Technology
Start price
Target price
Perf. (%)
€362.60
27.07.23
27.07.23
€377.36
27.07.24
27.07.24
-37.84%
28.06.24
28.06.24
Align Technology
Start price
Target price
Perf. (%)
€362.60
27.07.23
27.07.23
€377.36
27.07.24
27.07.24
-37.84%
28.06.24
28.06.24
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.25
27.07.23
27.07.23
€40.00
27.07.24
27.07.24
-15.65%
28.06.24
28.06.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.25
27.07.23
27.07.23
€40.00
27.07.24
27.07.24
-15.65%
28.06.24
28.06.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€48.33
27.07.23
27.07.23
€57.00
27.07.24
27.07.24
-23.29%
28.06.24
28.06.24
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected